Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-159695

Xenbase Image ID: 159695


Figure 3. VPA exacerbates light-induced RD in a T17M rod opsin model. A, Dot blot analysis of VPA-treated T17M X. laevis and their WT siblings in cyclic light and dark-reared conditions. In cyclic light, the effects of genotype and treatment were significant (pg = 1.7 × 10−9, pt = 1.8 × 10−9) and VPA treatment modified the effect of genotype significantly (pi = 1.2 × 10−6). In the dark, there was no significant effect of genotype and no interaction between VPA and genotype (pg = 0.56, pt = 0.029, pi = 0.67). n = 6–16 animals per group. Error bars indicate SEM. B, Representative low-magnification confocal micrographs of cryosections from transgenic retinas expressing T17M rod opsin stained with WGA. Scale bar, 200 μm. C, Representative high-magnification confocal micrographs of transgenic retinas expressing P23H rod opsin stained with 2B2 anti-mammalian rhodopsin (green), WGA (red), and Hoechst dye (blue). Neither dark rearing nor VPA treatment altered the distribution of T17M rod opsin significantly. ONL, Outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer. Scale bar, 50 μm. D, Total rod opsin (B630N) and T17M rhodopsin (1D4) signals were quantified in dot blot analyses of dark-reared animals. Two-way ANOVA analysis showed no significant effects of treatment on antibody signals, indicating that VPA treatment did not alter T17M rhodopsin expression levels. n = 11–13 animals for each condition.

Image published in: Vent-Schmidt RYJ et al. (2017)

Copyright © 2017. This image is reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.

GeneSynonymsSpeciesStage(s)Tissue
rho.Lopn2, rh1, rhodopsin, rp4, xrhoX. laevisThroughout NF stage 48retina

Image source: Published

Experiment + Assay Source Phenotypes and Disease
Xla.Tg(rho:Hsa.rhosub_T17M) + Valproate + NF48 (Other Detection Assay) Fig.3.A
Disease
retinitis pigmentosa
Expression Phenotype
decreased amount rho.L expression in eye
Xla.Tg(rho:Hsa.rhosub_T17M) + Valproate + NF48 (stained tissue microscopy) Fig.3.B,C
Anatomical Phenotype
abnormal photoreceptor layer morphology
abnormally decreased number of eye photoreceptor cell
Disease
retinitis pigmentosa

Larger Image
Printer Friendly View

Return to previous page